BeiGene's Brukinsa PFS Win Lifts China Biotech Stocks

Bests Imbruvica In CLL

 
• By Dexter Jie Yan
  
best in class concept
Prospects of a China innovative drug outdoing a global rival help sharp rebound in Chinese biotech shares • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia